Health ❯ Healthcare ❯ Medications

GLP-1 Drugs

Semaglutide Ozempic Weight Loss Obesity Treatment Wegovy Side Effects Mounjaro Oral Health Issues Obesity Treatments Ozempic and Mounjaro Eli Lilly and Novo Nordisk Usage Statistics Tirzepatide Osteomalacia Gout Prescription Management Osteoporosis Off-label Uses Heart Health Wegovy and Mounjaro Weight Loss Treatments Ozempic and Wegovy Type 2 Diabetes Novo Nordisk Economic Impact Health Outcomes Comparative Effectiveness Benefits and Side Effects Wegovy and Zepbound Lifestyle Interventions Alcohol Consumption Breast Cancer Prevention

Bank of America Says It Pays Over $250 Million a Year for GLP‑1 Drugs

The outlay equals about 13% of the bank’s more than $2 billion annual health budget and spotlights the strain of rising weight‑loss drug costs on large employers.

New Data Tie GLP-1 Drugs’ Broad Benefits to Inflammation

GLP-1 Drugs Linked to Lower Addiction Risk and Harm in Large VA Study

Most Weight Lost on GLP-1 Drugs Returns After Stopping, New Analysis Finds

Bariatric Surgery’s Long-Term Edge Holds Across Social Vulnerability, ARMMS-T2D Analysis Finds

KFF Survey: States See Rising Medicaid Costs and Likely 2026 Shortfalls Despite Enrollment Declines

Omada Health to Offer Nationwide GLP-1 Prescribing With Medication Management

Meghan Trainor Shares Toned-Abs Gym Selfie as Trainer Highlights Her Work Over Mounjaro